<VariationArchive RecordType="classified" VariationID="56224" VariationName="NM_000390.4(CHM):c.1609+2dup" VariationType="Duplication" Accession="VCV000056224" Version="3" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-01-07" DateCreated="2013-07-24" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70863" VariationID="56224">
      <GeneList>
        <Gene Symbol="CHM" FullName="CHM Rab escort protein" GeneID="1121" HGNC_ID="HGNC:1940" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="85861180" stop="86047558" display_start="85861180" display_stop="86047558" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="85116184" stop="85302565" display_start="85116184" display_stop="85302565" Strand="-" />
          </Location>
          <OMIM>300390</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHM">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000390.4(CHM):c.1609+2dup</Name>
      <CanonicalSPDI>NC_000023.11:85878962:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="85878962" stop="85878963" display_start="85878962" display_stop="85878963" variantLength="1" positionVCF="85878962" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="85133967" stop="85133968" display_start="85133967" display_stop="85133968" variantLength="1" positionVCF="85133967" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <OtherNameList>
        <Name>IVS13DS, INS T, +2</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_699t1" sequenceAccession="LRG_699t1" change="c.1609+2dup">
            <Expression>LRG_699t1:c.1609+2dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.85133968dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.85133968dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.85878963dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.85878963dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009874.2" sequenceAccession="NG_009874" sequenceVersion="2" change="g.173600dup">
            <Expression>NG_009874.2:g.173600dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000390.4" sequenceAccession="NM_000390" sequenceVersion="4" change="c.1609+2dup" MANESelect="true">
            <Expression>NM_000390.4:c.1609+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362519.1" sequenceAccession="NM_001362519" sequenceVersion="1" change="c.1165+2dup">
            <Expression>NM_001362519.1:c.1165+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362517.1" sequenceAccession="NM_001362517" sequenceVersion="1" change="c.1165+2dup">
            <Expression>NM_001362517.1:c.1165+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320959.1" sequenceAccession="NM_001320959" sequenceVersion="1" change="c.1165+2dup">
            <Expression>NM_001320959.1:c.1165+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362518.2" sequenceAccession="NM_001362518" sequenceVersion="2" change="c.1165+2dup">
            <Expression>NM_001362518.2:c.1165+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_699" sequenceAccession="LRG_699" change="g.173600dup">
            <Expression>LRG_699:g.173600dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA344729" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300390.0001" DB="OMIM" />
        <XRef Type="rs" ID="386833676" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000390.4(CHM):c.1609+2dup AND Choroideremia" Accession="RCV000049636" Version="3">
        <ClassifiedConditionList TraitSetID="3083">
          <ClassifiedCondition DB="MedGen" ID="C0008525">Choroideremia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000390.4(CHM):c.1609+2dup AND Choroideremia, Salla type" Accession="RCV002281558" Version="1">
        <ClassifiedConditionList TraitSetID="3082">
          <ClassifiedCondition DB="MedGen" ID="C4016478">Choroideremia, Salla type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1994-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1994-07-01" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-07-24" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1302003</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7981670</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301511</ID>
          <ID Source="BookShelf">NBK1337</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3082" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10874" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Choroideremia, Salla type</ElementValue>
              </Name>
              <XRef ID="C4016478" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3083" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="806" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Choroideremia</ElementValue>
                <XRef ID="2655" DB="GeneTests" />
                <XRef ID="Choroideremia/1395" DB="Genetic Alliance" />
                <XRef ID="HP:0001139" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0010557" DB="MONDO" />
                <XRef ID="75241009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive tapetochoroidal dystrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHM</ElementValue>
                <XRef Type="MIM" ID="303100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TCD</ElementValue>
                <XRef Type="MIM" ID="303100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder signs in heterozygous (carrier) females. Typically, symptoms in affected males evolve from night blindness to peripheral visual field loss, with central vision preserved until late in life. Although carrier females are generally asymptomatic, signs of chorioretinal degeneration can be reliably observed with fundus autofluorescence imaging, and – after age 25 years – with careful fundus examination.</Attribute>
                <XRef ID="NBK1337" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6061" />
                <XRef ID="6061" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301511</ID>
                <ID Source="BookShelf">NBK1337</ID>
              </Citation>
              <XRef ID="180" DB="Orphanet" />
              <XRef ID="C0008525" DB="MedGen" />
              <XRef ID="MONDO:0010557" DB="MONDO" />
              <XRef Type="MIM" ID="303100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001139" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="131432" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS1290" />
        <ClinVarAccession Accession="SCV000082043" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">1302003</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000390.2:c.1609+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Choroideremia</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="303100" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32130" SubmissionDate="2017-06-12" DateLastUpdated="2017-06-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300390.0001_CHOROIDEREMIA, SALLA TYPE" title="CHM, IVS13DS, INS T, +2_CHOROIDEREMIA, SALLA TYPE" />
        <ClinVarAccession Accession="SCV000032130" DateUpdated="2017-06-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1994-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Sankila et al. (1992) described a point mutation that is responsible for choroideremia (303100) in the large Salla pedigree from northeastern Finnish Lapland that accounts for one-fifth of the world's choroideremia patients. They showed that the mutation is unique in that it is not responsible for choroideremia in any of the other Finnish pedigrees. The mutation was detected by single-strand conformation polymorphism (SSCP) analysis with subsequent sequencing of the relevant DNA segment. Sequencing showed insertion of a T within the splice donor site of the intron downstream of exon C, changing the normal sequence of AGgtaag to AGgttaag. A new restriction site for MseI was created by the mutation, thus permitting screening. Although the CHM gene is mainly expressed in the retina, choroid, and retinal pigment epithelium, low levels of transcripts are also found in lymphoblasts by means of polymerase chain reaction (PCR). This illegitimate transcription provides a convenient means of screening and analyzing the transcript. Lymphoblast-derived mRNA from a patient with what the authors referred to as the CHM*SAL mutation showed 2 aberrantly spliced mRNAs and no normal transcript.</Attribute>
              <Citation>
                <ID Source="PubMed">1302003</ID>
              </Citation>
              <XRef DB="OMIM" ID="303100" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">According to the CHM sequence published by van Bokhoven et al. (1994), this mutation is referred to as 1639+2insT in intron 13.</Attribute>
              <Citation>
                <ID Source="PubMed">7981670</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHM" />
          </GeneList>
          <Name>CHM, IVS13DS, INS T, +2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS13DS, INS T, +2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300390.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHOROIDEREMIA, SALLA TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="383227" SubmissionDate="2015-02-26" DateLastUpdated="2022-10-01" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_000390.2:c.1609+2dupT|OMIM:303100" />
        <ClinVarAccession Accession="SCV000212130" DateUpdated="2022-10-01" DateCreated="2015-10-05" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1302003</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK1337</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000390.2:c.1609+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0008525" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32130" TraitType="Disease" MappingType="Name" MappingValue="CHOROIDEREMIA, SALLA TYPE" MappingRef="Preferred">
        <MedGen CUI="C4016478" Name="Choroideremia, Salla type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131432" TraitType="Disease" MappingType="Name" MappingValue="Choroideremia" MappingRef="Preferred">
        <MedGen CUI="C0008525" Name="Choroideremia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="383227" TraitType="Disease" MappingType="XRef" MappingValue="C0008525" MappingRef="MedGen">
        <MedGen CUI="C0008525" Name="Choroideremia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

